Mirza Mansoor Raza

Mirza Mansoor Raza is listed in filings as Chief Medical Officer at Acrivon Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through May 20, 2026, including sale activity. Recent filings connect the profile to Acrivon Therapeutics, Inc. Common Stock (ACRV), Sera Prognostics, Inc. (SERA), and Karyopharm Therapeutics Inc. (KPTI). The current snapshot covers public activity from Aug 8, 2024 to May 20, 2026. Reported amounts are shown as $262.8K to $672. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.